Parents often ask how DNA-based genetic screening compares to the standard state newborn screen, and which one covers more. The short answer: they use different technology, and genetic screening covers far more conditions.
State newborn screening
State screening uses biochemical tests to check a fixed panel of roughly 30 to 80 conditions, focused on urgent, treatable disorders. It is free, automatic, and an essential first line.
Genetic (genomic) screening
Genetic screening reads the baby’s DNA directly, so a single test can assess more than 1,000 clinically actionable conditions, plus medication-response markers, including many treatable conditions that are not on any state panel.
Which covers more?
Genetic screening, by a wide margin. The limit on state panels is budget and the slow adoption process, not the technology. The two are complementary: state screening handles the urgent essentials, and genomic screening adds breadth. See what Fore screens for or start screening.
Frequently asked questions
Is genetic screening a replacement for state screening?
No. It is a complement. State screening is automatic and covers urgent conditions; genetic screening broadens the picture.
Why does genetic screening cover so many more conditions?
Because it reads DNA directly rather than measuring a fixed set of biochemical markers, so one test can look at the genes behind 1,000+ conditions.
Medically reviewed by Fore’s Clinical Team. This article is for general educational purposes and is not medical advice. Sources: HRSA Recommended Uniform Screening Panel.